Jump to content

ATC code A14

From Wikipedia, the free encyclopedia

ATC code A14 Anabolic agents for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A14 is part of the anatomical group A Alimentary tract and metabolism.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA14.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A14AA Androstan derivatives

[edit]
A14AA01 Androstanolone
A14AA02 Stanozolol
A14AA03 Metandienone
A14AA04 Metenolone
A14AA05 Oxymetholone
A14AA06 Quinbolone
A14AA07 Prasterone
A14AA08 Oxandrolone
A14AA09 Norethandrolone

A14AB Estren derivatives

[edit]
A14AB01 Nandrolone
A14AB02 Ethylestrenol
A14AB03 Oxabolone cipionate

A14B Other anabolic agents

[edit]

References

[edit]
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code A14". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QA14". WHO Collaborating Centre for Drug Statistics Methodology.